PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsImatinib mesylate
Imatinib mesylate
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
780 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Bcr-abl positive chronic myelogenous leukemiaD015464EFO_0000340—123024111482
LeukemiaD007938—C9511351881073
Myeloid leukemiaD007951—C9210241881062
Gastrointestinal stromal tumorsD046152EFO_0000505C49.A61554230
Philadelphia chromosomeD010677——3732—13
Myeloid leukemia chronic-phaseD015466——3641112
Blast crisisD001752——1413210
Breast neoplasmsD001943EFO_0003869C50—2—1—3
Myeloproliferative disordersD009196—D47.1—1—1—2
Congenital abnormalitiesD000013EFO_0003915Q89.9———1—1
Show 2 more
Indications Phases 3
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Precursor cell lymphoblastic leukemia-lymphomaD054198—C91.079———12
Lymphoid leukemiaD007945—C9179———11
NeoplasmsD009369—C8046———9
SyndromeD013577——16——17
Lung neoplasmsD008175—C34.90—6———6
Prostatic neoplasmsD011471—C6125———6
Hypereosinophilic syndromeD017681EFO_1001467D72.1115——16
MelanomaD008545——15———5
Systemic sclerodermaD012595EFO_0000717M3415———5
Diffuse sclerodermaD045743EFO_0000404—15———5
Show 60 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients———5————5
Colonic neoplasmsD003110—C181————1
Malignant mesotheliomaD000086002——1————1
MesotheliomaD008654—C451————1
GliomaD005910EFO_0000520—1————1
Bronchiolitis obliterans syndromeD000092122—D89.8111————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Stomach neoplasmsD013274EFO_0003897C16————11
Polycythemia veraD011087—D45————11
PolycythemiaD011086EFO_0005804D75.1————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 9,999 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
55,717 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use